Idarucizumab Dosing in Kidney Failure

Am J Kidney Dis. 2018 Jan;71(1):146. doi: 10.1053/j.ajkd.2017.08.012. Epub 2017 Oct 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Kidney Injury*
  • Antibodies, Monoclonal, Humanized
  • Dabigatran
  • Humans
  • Liver Diseases*

Substances

  • Antibodies, Monoclonal, Humanized
  • idarucizumab
  • Dabigatran